拜切 BCPC 深 沪
已收盘 02-06 16:00:00 美东时间
173.16
-0.560
-0.32%
华盛通- 最 高176.55
- 今 开174.98
- 成交量 17.84万股
- 最 低 173.13
- 昨 收 173.72
- 总市值 56.08亿
- 52周最高 176.55
- 市盈率 静 44.10
- 换手率 0.55%
- 52周最低 138.21
- 委 比 94.17%
- 总股本 3238.63万
- 历史最高 184.20
- 量 比 1.18
- 振 幅 1.97%
- 历史最低 19.58
- 每 手 1
- 风险率 7.06%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Balchem Corporation to Attend the CJS Securities 26th Annual New Ideas for the New Year Virtual Conference on January 14, 2026
Balchem Corporation, a global specialty ingredient manufacturer for health and nutrition markets, will attend the CJS Securities 26th Annual New Ideas for the New Year Virtual Conference on January 14, 2026. Ted Harris, Chairman, CEO; Martin Bengtsson, CFO; and Allison Baurichter, Senior Director Investor Relations, will represent the company. Balchem operates in three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty P...
01-02 12:00
Balchem Announces Dividend Increase and Stock Buyback
Balchem ( ($BCPC) ) has provided an announcement. On December 9, 2025, Balchem ...
2025-12-11 05:56
Balchem declares $0.96 dividend
Balchem (BCPC) declared $0.96/share annual dividend, 10.3% increase from prior dividend of $0.87. Forward yield 0.64% Payable Jan. 20; for shareholders of record Dec. 23; ex-div Dec. 23. See BCPC Divi...
2025-12-11 05:25
Balchem Corporation Announces Dividend
Balchem Corporation (NASDAQ: BCPC) announced a dividend of $0.96 per share on its common stock, representing a 10.3% increase over last year's annual dividend. The dividend will be payable on January 20, 2026, to shareholders of record as of December 23, 2025. This marks the seventeenth consecutive annual dividend increase, reflecting the company's strong financial performance and board confidence in its long-term strategies. Balchem, headquarter...
2025-12-10 21:15
美股大行评级 | 高盛上调梅西百货目标价至22美元！ 摩根大通上调美国铝业公司目标价至45美元
今日重点评级关注：Stifel：维持X4 Pharmaceuticals"买入"评级，目标价从7.5美元升至10美元；花旗：维持UP Fintech Holding"买入"评级，目标价从17.4美元升至17.5美元
2025-12-08 08:34
Rothschild & Co Initiates Coverage On Balchem with Neutral Rating, Announces Price Target of $162
Rothschild & Co analyst Artem Chubarov initiates coverage on Balchem (NASDAQ:BCPC) with a Neutral rating and announces Price Target of $162.
2025-12-05 23:12
Balchem Corporation to Present at Baird’s 55th Annual Global Industrial Conference on November 12, 2025
Balchem Corporation, a global specialty ingredient manufacturer, will present at Baird’s 55th Annual Global Industrial Conference on November 12, 2025. Ted Harris, Martin Bengtsson, and Allison Baurichter will represent the company. Balchem provides innovative solutions for human, animal, and specialty markets, offering ingredients for food, supplements, pharmaceuticals, animal health, and agriculture.
2025-10-30 13:17
美股大行评级 | 超配！万事达、Visa、Block获多家机构首予评级；奈飞、德州仪器遭多家机构下调目标价
今日重点评级关注：Canaccord Genuity：维持ATAI Life Sciences"买入"评级，目标价从11美元升至14美元；麦格理：维持Cleanspark"跑赢大市"评级，目标价从20美元升至30美元
2025-10-23 10:06
HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $190
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and raises the price target from $189 to $190.
2025-10-22 19:53
Balchem Corporation Reports Record Third-Quarter Growth
Balchem ( ($BCPC) ) has released its Q3 earnings. Here is a breakdown of the in...
2025-10-22 11:58
